期刊文献+

慢性髓系白血病不同病期基因表达谱研究 被引量:1

Differential Expression Genes in Various Phases of Chronic Myeloid Leukemia by cDNA Microarray
下载PDF
导出
摘要 本研究旨在探讨慢性髓系白血病(chronic myeloid leukemia,CML)急变的分子机制。采用cDNA微重排方法对4例CML急变期、4例CML慢性期患者进行基因差异表达分析。结果显示,共筛选出至少在3张芯片有差异表达的基因74条,其中下调52条,上调22条;差异表达基因包括:细胞骨架/运动相关基因、信号传导相关基因、转录因子相关基因、免疫相关基因、代谢相关基因、细胞周期相关基因、原癌和抑癌基因、细胞受体相关基因、蛋白质翻译合成相关基因及功能未知的基因等。结论:急变是多基因异常相互作用的结果,其中功能异常的信号转导、细胞周期调控、细胞分化及免疫的相关基因可能是导致CML急变的关键基因。 The aim of this study was to explore the mechanism underlying the blast crisis of chronic myeloid leukemia. Analysis of gene expression profiles of chronic myeloid leukemia patients in chronic phase and blast crisis were analyzed by using cDNA microarray representing 4096 genes for finding the differential expression genes. The results indicated that 74 differential expression genes were identified in at least 3 gene chips in blast crisis compared with chronic phase, among them 52 genes were down-regulated and 22 genes were up-regulated in blast crisis. The differential expression genes were involved in these genes including genes related to cell structure/mobility, signal transduction, transcription factor, related immunity, metabolism, cell cycle, oncogene/anti-oncogene, cell receptor, protein translation/synthesis and some unknown functions. It is concluded that the blast crisis of CML is resulted from abnormality and interaction of multigenes, among them functional abnormal genes related to signal transduction, cell cycle, cell differentiation and immunity may be the critical genes for chronic myeloid leukemia blast crisis.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第3期575-578,共4页 Journal of Experimental Hematology
基金 吉林省科技厅基金资助项目 编号6046
关键词 慢性髓系白血病 CDNA微阵列 基因表达谱 chronic myeloid leukemia cDNA microarray gene expression profile
  • 相关文献

参考文献2

二级参考文献25

  • 1Zang DY, Goodwin RG, Loken MR, et al. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its reeptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood, 2001; 98:3058- 3065
  • 2Zannettino AC, Buhring HJ, Niutta S, et al. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood, 1998; 92:
  • 3Doyonnas R, Yi-Hsin Chan J, Butler LH, et al. CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor.J Immunol, 2000; 165:840 851
  • 4Tien HF, Tang JH, Tsay W, et al. Methylation of the p15 (INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol, 2001; 112:148154
  • 5Bellamy WT, Richter L, Sirjani D, et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood, 2001; 97:1427 - 1434
  • 6Wellmann A, Thieblemont C, Pittaluga S, et al. Detection of differentially expressed genes in lymphomas using cDNA arrays: iden tification of clustering as a new diagnostic marker for anaplastic large-cell lymphomas. Blood, 2000; 96: 398 - 404
  • 7Guidez F, Ivins S, Zhu J, et al. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood, 1998; 91:2634-2642
  • 8Mundle SD, Shetty VT, Raza A. Caspases and apoptosis in myelodysplastic syndromes. Exp Hematol, 2000; 28:1310 - 1312
  • 9Bartram CR. Molecular genetic aspects of myelodysplastic syndromes. Semin Hematol, 1996; 33:139 - 149
  • 10Puskas LG, Zvara A, Hackler L Jr, et al. RNA amplification results in reproducible microarray data with slight ratio bias. Biotechniques, 2002; 32:1330-1334, 1336, 1338, 1340

共引文献3

同被引文献43

  • 1Tefferi A,Vardiman Jw.Classification and diagnosis of myeloproliferative neoplasms:the 2008 World HealthOrganization criteria and point-of-care diagnostic algorithms[J].Leukemia,2008,22(1):14-22.
  • 2James C,Ugo V,LE COUEDIC,et al.A unique clonal JAK2mutation leading to constitutive signaling causes polycythemiavera[J].Nature,2005,434(7037):1144-1148.
  • 3Dalal I,Arpaia E,Dadi H,et al.Cloning and characterization ofthe human homolog of mouse Jak2[J].Blood,1998,91(3):844-851.
  • 4Baxter EJ,Seott LM,Campbell PJ,et al.Acquired mutation ofthe tyrosine kinase JAK2in human myeloproliferative disorders[J].Lancet,2005,365(9464):1054-1061.
  • 5Zeuner A,Pedini F,Signore M,et al.Increased death receptorresistance and FLIP short expression in polycythemia veraerythroid precursor cells[J].Blood,2006,107(9):3459-3502.
  • 6Scott LM,Tong W,Levine RL,et al.JAK2exon 12mutationsin polycythemia vera and idiopathic erythrocytosis[J].N Engl JMed,2007,356(5):459-468.
  • 7Pardanani AD,Levine RL,Lasho T,et al.MPL 515mutationsin myeloproliferative and other myeloid disorders:a study of1182patients[J].Blood,2006,108(10):3472-3476.
  • 8Pikman Y,Lee BH,Mercher T,et al.MPLW515Lis a novelsomatic activating mutation in myelofibrosis with myeloidmetaplasia[J].PLoS Med,2006,3(7):270.
  • 9Beer PA,Campbell PJ,Scott LM,et al.MPL mutations inmyeloproliferative disorders:analysis of the PT-1cohort[J].Blood,2008,112(1):141-149.
  • 10Vannucchi AM,Antonioli E,Guglielmelli P,et al.Characteristics and clinical correlates of MPL 515W>L/Kmutation in essential thrombocythemia[J].Blood,2008,112(3):844-847.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部